Neurology & Neurotherapeutics - NE Multiple Sclerosis Section

Research output

Research output per year 1986 2008 2009 2010 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

• 489 Article
• 119 Review article
• 42 Letter
• 21 Editorial
• 30 More
  • 15 Comment/debate
  • 10 Chapter
  • 3 Short survey
  • 1 Book
  • 1 Conference contribution

Research output per year

Research output per year

Search results

• An in vivo assessment of the brain in Alzheimer's disease.

  Frohman, E. & van den Noort, S., Apr 1 1986, In: The Western journal of medicine. 144, 4, 1 p.

  Research output: Contribution to journal › Letter › peer-review

• Anticipated benefits and surprising effects of daclizumab in multiple sclerosis

  Stüve, O. & Greenberg, B. M., Apr 2010, In: The Lancet Neurology. 9, 4, p. 337-338 2 p.

  Research output: Contribution to journal › Letter › peer-review
  4 Scopus citations

• Application of diagnostic criteria for optic neuritis – Authors' reply

  International Consortium on Optic Neuritis (ICON), May 2023, In: The Lancet Neurology. 22, 5, p. 376-377 2 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Asymptomatic retinal vasculopathy in neuropsychiatric systemic lupus erythematosus

  Sguigna, P. V., Tardo, L., Conger, D., Hogan, R. & Greenberg, B. M., Nov 15 2021, In: Journal of the Neurological Sciences. 430, 118053.

  Research output: Contribution to journal › Letter › peer-review
  1 Scopus citations

• Author response

  Zee, D. S., Beh, S. C. & Kheradmand, A., Nov 11 2014, In: Neurology. 83, 20, p. 1879 1 p.

  Research output: Contribution to journal › Letter › peer-review

• Autologous HSCT for advanced MS: Is the glass half-empty or really half-full? [1]

  Nash, R. A., Stuve, O., Bowen, J. D., Frohman, E., Griffith, L. M., Hutton, G. J., Kraft, G. H., Popat, U., Racke, M. K. & Muraro, P. A., Feb 2008, In: Brain. 131, 2, p. e89

  Research output: Contribution to journal › Letter › peer-review
  6 Scopus citations

• COVID-19 in the pregnant or postpartum MS patient: Symptoms and outcomes

  Salter, A., Cross, A. H., Cutter, G. R., Fox, R. J., Li, D. K. B., Bebo, B., Halper, J., Kanellis, P., Rammohan, K. & Newsome, S. D., Sep 2022, In: Multiple Sclerosis and Related Disorders. 65, 104028.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

  • Postpartum Period 100%
  • Multiple Sclerosis 92%
  • Propensity Score 22%
  • Registries 16%
  3 Scopus citations

• Effective suppression of cerebrospinal fluid B cells by rituximab and cyclophosphamide in progressive multiple sclerosis [2] (multiple letters)

  Petereit, H. F., Rubbert, A. & Monson, N. L., Oct 2005, In: Archives of neurology. 62, 10, p. 1641-1642 2 p.

  Research output: Contribution to journal › Letter › peer-review
  19 Scopus citations

• Evaluating retinal abnormalities in patients with multiple sclerosis - Reply

  Balcer, L. J., Frohman, E., Calabresi, P. A. & Galetta, S. L., Aug 2010, In: Archives of neurology. 67, 8, p. 1035-1036 2 p.

  Research output: Contribution to journal › Letter › peer-review

• Extended-interval dosing of natalizumab in NOVA

  Stüve, O. & Tugemann, B., Mar 2023, In: The Lancet Neurology. 22, 3, p. 199-200 2 p.

  Research output: Contribution to journal › Letter › peer-review
  2 Scopus citations

• Focal lesion in the splenium of the corpus callosum

  Okuda, D. T., Jun 2008, In: Archives of neurology. 65, 6, 1 p.

  Research output: Contribution to journal › Letter › peer-review
  1 Scopus citations

• Gender Inequities in the Multiple Sclerosis Community: A Call for Action

  International Women in MS, Dec 1 2018, In: Annals of Neurology. 84, 6, p. 958-959 2 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  9 Scopus citations

• Handedness and potential implications for neurorehabilitation in multiple sclerosis

  Shirani, A. & Okuda, D. T., Jan 2020, In: Multiple Sclerosis and Related Disorders. 37, 101405.

  Research output: Contribution to journal › Letter › peer-review
  1 Scopus citations

• High incidence of post-lumbar puncture headaches in patients with multiple sclerosis treated with natalizumab: Role of intrathecal leukocytes [1]

  Stuve, O., Cravens, P. D., Singh, M. P., Frohman, E., Phillips, J. T., Remington, G., Hu, W., Hemmer, B., Olek, M. J., Monson, N. L. & Racke, M. K., Jul 2007, In: Archives of neurology. 64, 7, p. 1055-1056 2 p.

  Research output: Contribution to journal › Letter › peer-review
  2 Scopus citations

• Humoral immune responses after rabies infection [1]

  Watson, N. F., Woo, D., Doherty, M. J., Frohman, E., Racke, M. K., De Baets, M., Hartung, H. P., Kieseier, B. C. & Stuve, O., Sep 2007, In: Archives of neurology. 64, 9, p. 1355-1356 2 p.

  Research output: Contribution to journal › Letter › peer-review
  6 Scopus citations

• In reply

  Greenberg, B. M., Wingerchuk, D., Mealy, M. & Levy, M., Feb 2013, In: JAMA neurology. 70, 2, p. 273 1 p.

  Research output: Contribution to journal › Letter › peer-review

• In Reply

  Greenberg, B. M. & Williams, M., Jun 2010, In: Neurosurgery. 66, 6, p. E1217

  Research output: Contribution to journal › Letter › peer-review

• In reply [4]

  Monson, N. L., Racke, M. K. & Frohman, E., May 2006, In: Archives of neurology. 63, 5, p. 787-788 2 p.

  Research output: Contribution to journal › Letter › peer-review

• JC viremia in natalizumab-treated patients with multiple sclerosis

  Major, E. O., Frohman, E. & Douek, D., 2013, In: New England Journal of Medicine. 368, 23, p. 2240-2241 2 p.

  Research output: Contribution to journal › Letter › peer-review
  61 Scopus citations

• Letter to the Editor Regarding “Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder”

  Cree, B. A. C., Greenberg, B., Cameron, C. & Weinshenker, B. G., Sep 2022, In: Neurology and Therapy. 11, 3, p. 1439-1443 5 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  5 Scopus citations

• Looking beyond head trauma

  Okuda, D. T., Nov 21 2008, In: Science. 322, 5905, p. 1186 1 p.

  Research output: Contribution to journal › Letter › peer-review

• More on multiple sclerosis and neuromyelitis optica: In reply [5]

  Weinshenker, B., Galetta, S., Bennett, J., Kerr, D. & Frohman, E., Dec 2007, In: Archives of neurology. 64, 12, p. 1802-1803 2 p.

  Research output: Contribution to journal › Letter › peer-review
  1 Scopus citations

• NMDA receptor antibody seropositivity in psychosis: A pilot study from the Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP)

  Blackburn, K. M., Ivleva, E. I., Weir, R. A., Kim, M., Hopkins, S. C., Hudgens-Haney, M. E., Keedy, S. K., Gershon, E. S., Sweeney, J. A., Keshavan, M. S., Pearlson, G. D., Clementz, B. A., Tamminga, C. A. & Vernino, S., Apr 2020, In: Schizophrenia Research. 218, p. 318-320 3 p.

  Research output: Contribution to journal › Letter › peer-review
  3 Scopus citations

• Noninvasive Vagus Nerve Stimulation for Nausea Prevention During BPPV Treatment

  Beh, S. C., Aug 1 2020, In: Neuromodulation. 23, 6, p. 886-887 2 p.

  Research output: Contribution to journal › Letter › peer-review
  3 Scopus citations

• Overdiagnosis of multiple sclerosis by magnetic resonance imaging [1]

  Goodin, D. S. & Frohman, E., Mar 2006, In: Annals of Neurology. 59, 3, p. 575-576 2 p.

  Research output: Contribution to journal › Letter › peer-review
  4 Scopus citations

• Peripheral nerve involvement in adult and pediatric patients with central nervous system inflammatory disease - In reply

  Greenberg, B. M., Jan 1 2015, In: JAMA neurology. 72, 1, p. 123-124 2 p.

  Research output: Contribution to journal › Letter › peer-review

• Quantitative sensory testing: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology [1] (multiple letters)

  Spielholz, N. I., Dyck, P. J., O'Brien, P. C., Shy, M. E. & Frohman, E., Dec 9 2003, In: Neurology. 61, 11, p. 1628-1630 3 p.

  Research output: Contribution to journal › Letter › peer-review
  3 Scopus citations

• Relevance of CD34+ cells as a reservoir for JC virus in patients with multiple sclerosis - Reply

  Frohman, E., Douek, D. & Major, E. O., Sep 1 2014, In: JAMA neurology. 71, 9, p. 1192-1193 2 p.

  Research output: Contribution to journal › Letter › peer-review

• Reply: Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography

  Saidha, S., Syc, S. B., Frohman, E. & Calabresi, P. A., Nov 2011, In: Brain. 134, 11, p. e194

  Research output: Contribution to journal › Letter › peer-review
  3 Scopus citations

• Reply from the authors

  Okuda, D. T., Nov 2009, In: Neurology. 73, 20, p. 1714 1 p.

  Research output: Contribution to journal › Letter › peer-review
  2 Scopus citations

• Reply from the authors

  Frohman, E., Beeravolu, L. R., Frohman, T. C., Remington, G. M., Lee, S. & Levin, M. C., Nov 2009, In: Neurology. 73, 21, p. 1812-1813 2 p.

  Research output: Contribution to journal › Letter › peer-review

• Reply from the authors [5]

  Greenberg, B. M. & Kerr, D., Jan 2008, In: Neurology. 70, 2, p. 160 1 p.

  Research output: Contribution to journal › Letter › peer-review

• Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis: Reply

  Calabresi, P. A., Lipkin, E. G., Chodkowski, B. A., Reich, D., Smith, S., Pulicken, M., Frohman, E., Balcer, L. & Cutter, G., Nov 18 2008, In: Neurology. 71, 21, p. 1747-1748 2 p.

  Research output: Contribution to journal › Letter › peer-review
  11 Scopus citations

• Retinal pathology in multiple sclerosis: Insight into the mechanisms of neuronal pathology

  Saidha, S., Syc, S. B., Balcer, L. J., Frohman, E. & Calabresi, P. A., May 2011, In: Brain. 134, 5, p. e172

  Research output: Contribution to journal › Letter › peer-review

• Should ocrelizumab be used in non-active primary progressive multiple sclerosis? Time for a re-assessment

  Manouchehri, N. & Stüve, O., 2021, In: Therapeutic Advances in Neurological Disorders. 14

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  6 Scopus citations

• Sodium Phenylbutyrate-Taurursodiol for ALS

  Herz, J. & Stüve, O., Dec 3 2020, In: The New England journal of medicine. 383, 23, p. 2294 1 p.

  Research output: Contribution to journal › Letter › peer-review

• The authors reply

  Major, E. O., Frohman, E. & Douek, D., 2013, In: New England Journal of Medicine. 369, 13, p. 1280 1 p.

  Research output: Contribution to journal › Letter › peer-review
  6 Scopus citations

• The utility of MRI in suspected MS: Report of the Therapeutics and Technology Assessment Subcommittee [4] (multiple letters)

  Uitdehaag, B. M. J., Geurts, J. J. G., Barkhof, F., Polman, C. H., Goodin, D. S. & Frohman, E., Sep 29 2004, In: Neurology. 63, 6, p. 1140 1 p.

  Research output: Contribution to journal › Letter › peer-review
  4 Scopus citations

• The utility of MRI in suspected MS: Report of the Therapeutics and Technology Assessment Subcommittee [3] (multiple letters)

  Gordon, J. M. & Frohman, E., Mar 9 2004, In: Neurology. 62, 5, p. 838 1 p.

  Research output: Contribution to journal › Letter › peer-review

• The “eye of the tiger” in a patient with multiple sclerosis

  Beh, S. C., Apr 15 2019, In: Journal of the Neurological Sciences. 399, p. 1-2 2 p.

  Research output: Contribution to journal › Letter › peer-review

• To the editors: Impact of mass vaccination on SARS-CoV-2 infections among multiple sclerosis patients taking immunomodulatory disease-modifying therapies in England

  Tugemann, B., Manouchehri, N. & Stuve, O., Mar 2022, In: Multiple Sclerosis and Related Disorders. 59, 103541.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  1 Scopus citations

• Utilization of video oculography to quantify oculomotor dysfunction in anti-DPPX encephalitis: A case study

  Blackburn, K., Vernino, S. & Sguigna, P., Nov 2020, In: Multiple Sclerosis and Related Disorders. 46, 102460.

  Research output: Contribution to journal › Letter › peer-review

  • 1,3-dipropyl-8-phenylxanthine 100%
  • Encephalitis 54%
  • Pathologic Nystagmus 35%
  • Immunotherapy 22%
  • Anti-Idiotypic Antibodies 21%
  1 Scopus citations